Pasithea Therapeutics rockets 132% after adding esketamine nasal spray to U.K. offerings
November 23 2021 - 8:19AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Pasithea Therapeutics (NASDAQ:KTTA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pasithea Therapeutics (NASDAQ:KTTA)
Historical Stock Chart
From Apr 2023 to Apr 2024